Home › NDC Lookup › RxCUI directory › RxCUI 2474033

10 ML margetuximab-cmkb 25 MG/ML Injection [Margenza] — RxCUI 2474033

RxNorm drug concept · Semantic branded drug
RxCUI 2474033 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2474033
Official name10 ML margetuximab-cmkb 25 MG/ML Injection [Margenza]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as10 ML Margenza 25 MG/ML Injection; Margenza 250 MG in 10 ML Injection; Margenza 250 MG per 10 ML Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Margetuximab-cmkb Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Margenza is a targeted antibody therapy approved for adults with metastatic HER2-positive breast cancer — meaning the cancer has spread and tests positive for a protein called HER2...
  • What exactly is Margenza and why has my doctor prescribed it?
  • Your first Margenza infusion will take about 2 hours. After that, if you tolerated it well, later infusions can be shortened to as little as 30 minutes. Infusions are given once ev...
  • What should I expect during my infusion appointments?
📖 Read our full Margetuximab-cmkb Injection guide →

🕸️ Concept Web — How 10 ML margetuximab-cmkb 25 MG/ML Injection [Marg... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 10 ML margetuximab-cmkb 25 MG/ML Injection [Margenza] RxCUI 2474033

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Margetuximab 2473851
    • Margetuximab-cmkb 2473850
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Margenza 2474029
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Margetuximab Injection 2474027
    • Margetuximab-cmkb Injection 2645766
    • Margetuximab Injectable Product 2474026
    • Margetuximab-cmkb Injectable Product 2661856
    • Margetuximab Injection [Margenza] 2474031
    • Margetuximab-cmkb Injection [Margenza] 2656806
    • Margenza Injectable Product 2474032
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 10 ML margetuximab-cmkb 25 MG/ML Injection SCD · 2474028
  • Margetuximab-cmkb 25 MG/ML SCDC · 2474025
  • Margetuximab Injection SCDF · 2474027
  • Margetuximab-cmkb Injection SCDFP · 2645766
  • Margetuximab Injectable Product SCDG · 2474026
  • Margetuximab-cmkb Injectable Product SCDGP · 2661856

Brand-Name Concepts

  • Margetuximab-cmkb 25 MG/ML [Margenza] SBDC · 2474030
  • Margetuximab Injection [Margenza] SBDF · 2474031
  • Margetuximab-cmkb Injection [Margenza] SBDFP · 2656806
  • Margenza Injectable Product SBDG · 2474032
  • Margenza BN · 2474029

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2474033 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
74527-0022-02 1 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-02) / 10 mL in 1... MARGENZA MacroGenics, Inc 2021-01-15
74527-0022-03 4 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-03) / 10 mL in 1... MARGENZA MacroGenics, Inc 2021-01-15
Observed labelers: MacroGenics, Inc (2) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9353 Inj. margetuximab-cmkb, 5 mg 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.